Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

hormonal · Mechanism Report

Does the menopause transition worsen body composition even if weight rises?

During the menopause transition, weight can rise while fat mass increases and lean mass decreases.

PlausibleSeptember 13, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Across the menopause transition, declining ovarian hormone stability is associated with increased fat mass and reduced lean mass, so body composition can worsen even when scale weight rises.

laying out figure…
3 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says that declining ovarian hormone stability across menopause is linked to a shift in body composition, not just a change on the scale. The graph frames this as increased fat mass and reduced lean mass contributing to a less favorable composition, including more central fat. It also notes that rising weight can hide these tissue changes.

Verified conclusion

Menopause transition is a period of measurable body-composition remodeling, particularly around the final menstrual period. The claim is supported: scale weight can rise while the underlying balance shifts toward more fat and less lean tissue.

Clinical evidence

  • In longitudinal SWAN DXA data, fat-mass gain accelerated from approximately 0.25 to 0.45 kg/year around the final menstrual period—an estimated ~6% (1.6-kg) increase across the transition—and continued for about 2 years afterward before largely plateauing.
  • Lean mass shifted from slight gain to decline about 2 years before the final menstrual period, with losses continuing for roughly 2 years after it.
  • Scale weight rose relatively linearly despite these changing tissue trajectories. Thus, a higher weight can reflect disproportionately greater fat mass while lean tissue declines, rather than simply “weight gain” of a uniform type.
  • In a 6-year SWAN substudy, mean changes included +3.4 kg fat mass, +5.7 cm waist circumference, and −0.23 kg skeletal muscle. Increased central/visceral adiposity is also characteristic of this transition.

Mechanisms and health relevance

  • Falling estradiol is a biologically credible contributor: reduced estrogen-receptor signaling can favor visceral fat deposition and inflammatory adipokine activity, while potentially impairing muscle mitochondrial function, lipid oxidation, repair, and protein-turnover balance.
  • Greater fat gain and greater lean-mass loss during the transition were each associated with higher subsequent fracture hazard in related SWAN analyses, although effects varied substantially among women.

Interpretation

  • Aging, activity, baseline adiposity, hormone therapy, and other midlife exposures also affect these outcomes; ovarian hormone change is an important associated contributor rather than a fully isolated cause.
  • DXA “lean mass” is not synonymous with skeletal muscle or sarcopenia.

Bottom line

  • During the menopause transition, rising scale weight can conceal an unfavorable shift toward higher—often more central—fat mass and lower lean mass; body-composition measures provide information that weight alone cannot.

References

  1. Changes in body composition and weight during the ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  2. FSH Level and Changes in Bone Mass and Body Composition in ... — academic.oup.com ↗
  3. Sarcopenia and Menopause: The Role of Estradiol — frontiersin.org ↗
  4. The menopause transition and women's health at midlife: a... : Menopause — journals.lww.com ↗
  5. Changes in body composition and weight during ... - PubMed — pubmed.ncbi.nlm.nih.gov ↗
  6. Changes in Body Composition in Women over Six Years at ... — academic.oup.com ↗
  7. a prospective study in Chinese perimenopausal women — pubmed.ncbi.nlm.nih.gov ↗
  8. Study of Women's Health Across the Nation | Journal of Bone ... — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible11 sourcesCan reduced thyroid hormone signaling lower energy and muscle function?→Plausible5 sourcesDoes declining ovarian reserve during perimenopause make ovulation less consistent and progesterone more variable?→